comprehensive -WSS

comprehensive

author：fashion 2025-09-27 13:10:46 - browse：3835

Portrait of Robert Langer. -- biotech coverage from STAT. — Serial biotech entrepreneur Bob Langer will serve as an adviser to T.rx Capital. Pat Greenhouse/Globe Staff

Executives from the shuttered digital health company Pear Therapeutics are launching a new VC firm, offering early access to new startups formed by serial biotech entrepreneur Bob Langer.

Former Pear CEO Corey McCann and former licensing head Michael Langer formed the new firm, T.rx Capital, earlier this year, according to three people with knowledge of the firm and documents reviewed by STAT. Michael Langer, the son of Bob Langer, confirmed the news and that they had set a $175 million cap for its first fund.

The firm will invest in therapeutics and digital health products by both forming new companies and taking pitches from early-stage startups. T.rx has brought in Everly Health executive Liz Kwo and Caris Life Sciences vice president Debbie Lin as venture partners, while current Eli Lilly business development team member Kwesi Frimpong-Boateng will be joining T.rx’s founding team. Bob Langer is a scientific adviser.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： Experimental asthma app from Apple and Anthem shows promise

entertainment

WSS

The pain doctors face in trying to build their families

Trump's false claims about Georgia's 2020 election long debunked

Publishing genetic code of viruses could cause disaster

Cancer diagnosis changes perspective doctor, former hospital CEO

Study suggests Covid rebound is far more common with Paxlovid than without

Readout LOUD Podcast: Lilly's obesity drug, the power of radiation

focus

comprehensive

hotspot

Hollywood unions extend contract negotiations for actors

An interview with Robert F. Kennedy Jr. on vaccines

Psychedelics group wrestles with new pharma identity

Ukraine taking heavy casualties 10 weeks into its counteroffensive

Medical leaders decry Supreme Court decision on affirmative action

ActiGraph execs on goal of drug approvals with digital endpoints

Medicare proposal to cover medical devices draws a mixed reaction

What health policies could hitch a ride on a spending bill?

In age of alternative facts, a scholarly course on calling out crap

What health policies could hitch a ride on a spending bill?

knowledge

Readout LOUD Podcast: Lilly's obesity drug, the power of radiation

Living with Hashimoto's and celiac disease, and med school, too

Listen: Racing for gene therapy & a pioneering approval

Ventyx halts psoriasis drug development after lackluster trial results

New definition of a human embryo proposed amid rapid advances

How state and local governments are sidelining science

hotspot

entertainment

hotspot

leisure time